Home » Parkinson’s Drug Awaits OK While ADHD Lifts Impax Now
Parkinson’s Drug Awaits OK While ADHD Lifts Impax Now
While its long-awaited novel drug to treat Parkinson’s disease inches closer to the finish line, Impax Laboratories has found other ways to keep its growth engine humming.
Investors Today
Investors Today
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May